The Beneficial Effects of the DPP-4 Inhibitor Alogliptin on Hemoglobin A1c and Serum Lipids in Japanese Patients with Type 2 Diabetes

  • M. Kusunoki, D. Sato, T. Nakamura, Y. Oshida, H. Tsutsui, Y. Natsume, K. Tsutsumi, T. Miyata
  • Drug Research, June 2015, Thieme Publishing Group
  • DOI: 10.1055/s-0035-1547254

The authors haven't yet claimed this publication.

Read Publication